UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 15,162	$ 11,027
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	577	489
Amortization	1,663	1,568
Gain on Investments	(32)	0
Provision for (recovery of) losses on accounts receivable	(1)	(2)
(Gain) loss on disposal of assets	(409)	0
Deferred income taxes	(352)	(281)
Stock-based compensation expense	53	99
Tax benefit attributable to exercise of stock options	44	25
Changes in operating assets and liabilities:
Accounts receivable	(948)	(1,340)
Accrued interest and other receivables	0	(5)
Inventories	255	(301)
Prepaid expenses and other current assets	52	40
Accounts payable	(258)	201
Accrued expenses	(3,455)	803
Total adjustments	(2,811)	1,296
Net cash provided by operating activities	12,351	12,323
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(255)	(174)
Intangible assets	0	0
Purchases of investments	0	0
Proceeds from sale of investments	74	0
Proceeds from sale of property and equipment	862	0
Net cash provided by (used in) investing activities	681	(174)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	436	224
Payment of dividends	(3,018)	(1,969)
Net cash provided by (used in) financing activities	(2,582)	(1,745)
Effect of exchange rate changes on cash	(973)	738
Net increase (decrease) in cash and cash equivalents	9,477	11,142
Cash at beginning of period	39,875	26,296
Cash at end of period	49,352	37,438
Cash paid during the period for income taxes	3,820	3,753
Cash paid during the period for interest	$ 0	$ 0